Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Page 1
Synthesis of the evidence: Clinical guideline for the diagnosis and treatment of precocious puberty.
Castilla-Peón MF, Torres-Tamayo M, Zurita-Cruz JN, Aguilar-Herrera BE, Miranda-Lora AL, Rivera-Hernández AJ, Calzada-León R, Morales-Pérez MA, Padrón-Martínez MM, Ruiz-Reyes ML, García-Morales LM, Barrón-Uribe C, Arguinzoniz-Valenzuela SL, Torres-Castañeda MC, Lizárraga-Paulin L, Núñez-Hernández JA, Cornejo-Barrera J, Vidal-González MT, Martínez-Alvarado MR, Nishimura-Meguro E, Bravo-Ríos LE, Garrido-Magaña EP, Orozco-Morales JA, Medina-Bravo PG, Coyote-Estrada N. Castilla-Peón MF, et al. Among authors: medina bravo pg. Bol Med Hosp Infant Mex. 2020;77(Supl 1):35-40. doi: 10.24875/BMHIM.20000087. Bol Med Hosp Infant Mex. 2020. PMID: 32614337 Free article. English.
Three systematic reviews were conducted to formulate the recommendations on diagnosis, treatment and follow-up of patients with precocious puberty: interventions for the treatment of precocious puberty that included the outcomes of final or near-final height, mental health, metab …
Three systematic reviews were conducted to formulate the recommendations on diagnosis, treatment and follow-up of patients with precocious p …
Methodology for the development of the Clinical guideline for the diagnosis and treatment of precocious puberty.
Torres-Tamayo M, Zurita-Cruz JN, Aguilar-Herrera BE, Miranda-Lora AL, Calzada-León R, Rivera-Hernández AJ, Morales-Pérez MA, Padrón-Martínez MM, Ruiz-Reyes ML, García-Morales LM, Barrón-Uribe C, Arguinzoniz-Valenzuela SL, Torres-Castañeda MC, Lizárraga-Paulin L, Núñez-Hernández JA, Cornejo-Barrera J, Vidal-González MT, Martínez-Alvarado MR, Nishimura-Meguro E, Bravo-Ríos LE, Garrido-Magaña EP, Orozco-Morales JA, Medina-Bravo PG, Coyote-Estrada N, Castilla-Peón MF. Torres-Tamayo M, et al. Among authors: medina bravo pg. Bol Med Hosp Infant Mex. 2020;77(Supl 1):1-6. doi: 10.24875/BMHIM.20000083. Bol Med Hosp Infant Mex. 2020. PMID: 32614334 Free article. English.
METHODS: Three systematic reviews were conducted: controlled clinical trials on interventions for PP treatment, diagnostic tests, and observational studies on the long-term effects of PP. The quality evaluation and data extraction from the studies were conducted by two ind …
METHODS: Three systematic reviews were conducted: controlled clinical trials on interventions for PP treatment, diagnostic tests, and observ …
Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium.
Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, Charmandari E, Lee PA, Freire AV, Ropelato MG, Yazid Jalaludin M, Mbogo J, Kanaka-Gantenbein C, Luo X, Eugster EA, Klein KO, Vogiatzi MG, Reifschneider K, Bamba V, Garcia Rudaz C, Kaplowitz P, Backeljauw P, Allen DB, Palmert MR, Harrington J, Guerra-Junior G, Stanley T, Torres Tamayo M, Miranda Lora AL, Bajpai A, Silverman LA, Miller BS, Dayal A, Horikawa R, Oberfield S, Rogol AD, Tajima T, Popovic J, Witchel SF, Rosenthal SM, Finlayson C, Hannema SE, Castilla-Peon MF, Mericq V, Medina Bravo PG. Bangalore Krishna K, et al. Among authors: medina bravo pg. Horm Res Paediatr. 2019;91(6):357-372. doi: 10.1159/000501336. Epub 2019 Jul 18. Horm Res Paediatr. 2019. PMID: 31319416 Free article. Review.
Topics related to the use of GnRHa in precocious puberty include diagnostic criteria, globally available formulations, considerations of benefit of treatment, monitoring of therapy, adverse events, and long-term outcome data. Additional sections review use in transgender i …
Topics related to the use of GnRHa in precocious puberty include diagnostic criteria, globally available formulations, considerations of ben …